Investigators reported the intensive bone marrow monitoring of minimal residual disease using flow cytometry and nested reverse transcription polymerase chain reaction (PCR) whenever a fusion transcript allowed it and chimerism by PCR at eleven timepoints in the first two years after transplant.
[Bone Marrow Transplantation]
7992332
{7992332:QLKB7E55}
apa
50
1
166413
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
